Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Gregory P. Bisson, MD, MSCE

Gregory P. Bisson, MD, MSCE Physician

Associate Professor of Medicine Associate Professor of Epidemiology in Biostatistics and Epidemiology

Dr. Bisson is employed by Penn Medicine.

No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.
X

About Dr. Gregory P. Bisson

Dr. Bisson sees and treats patients at the Philadelphia VA Medical Center.

Clinical Specialties

Specialty:

  • Infectious Diseases

Programs & Centers:

Clinical Expertise:

  • Aspergillosis
  • Bone Infection (Osteomyelitis)
  • C. Difficile (Clostridium Difficile Diarrhea)
  • Cellulitis
  • Flu (Influenza)
  • Flu Shot Vaccination
  • Genital Warts (Condyloma Acuminatum)
  • Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Herpes Simplex Virus (HSV)
  • HIV and AIDS
  • Joint Infection
  • Lyme Disease
  • Malaria
  • Meningitis
  • Mycobacterium
  • Pneumonia
  • Prosthetic Joint Infection
  • Sexually Transmitted Diseases (STD)
  • Shingles
  • Staph Infection
  • Swollen Lymph Nodes
  • Syphilis
  • Travelers' Diarrhea
  • Tuberculosis (TB)
View More

Insurance Accepted

  • OPR Medicare
  • OPR New Jersey Medicaid
  • OPR Pennsylvania Medicaid

Education and Training

Medical School: University of Minnesota - Minneapolis
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania

Memberships

Infectious Disease Society of America (IDSA), National National Institute of Health, AIDS Clinical Trials Group, National National Institute of Health, National Institute of Allergy and Infectious Disease (NIAID), Division of AIDS, National Society for Epidemiologic Research, National The International Union Against Tuberculosis and Lung Disease, International

Hospital Affiliation

Dr. Bisson is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: On the medical staff, but does not have privileges to treat patients in the hospital.

Research

Description of Research Expertise:

My research is dedicated to improving treatment outcomes of patients with HIV and tuberculosis (TB) and other AIDS-associated opportunistic infections. Current research projects are evaluating the relationship between very early virologic and immunologic response to antiretroviral therapy and clinical outcomes in adults with HIV/TB. Many patients with advanced HIV die soon after antiretroviral therapy initiation, and our research group focuses on trying to understand the pathophysiologic and social mechanisms underlying these early deaths. In addition, we are pursuing translational projects evaluating novel host-directed therapies for treatment of drug resistant TB.

Selected Publications:

Mehta K, Ravimohan S, Pasipanodya JG, Srivastava S, Modongo C, Zetola NM, Weissman D, Ivaturi V, Gumbo T, Bisson GP, Vinnard C: Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study J Antimicrob Chemother : pii: dkz265,2019.

Ravimohan S, Auld SC, Maenetje P, Ratsela N, Mlotshwa M, Ncube I, Smith JP, Vangu M-D-T, Sebe M, Kossenkov A, Weissman D, Wallis RS, Churchyard G, Kornfeld H, Bisson GP: Lung injury on antiretroviral therapy in adults with HIV/TB Clin Infect Dis : pii: ciz560,2019.

Torgersen J, Bellamy SL, Ratshaa B, Han X, Mosepele M, Zuppa AF, Vujkovic M, Steenhoff AP, Bisson GP, Gross R: Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans Eur J Drug Metab Pharmacokinet 44 (2): 179-187,2019.

Jarvis JN, Leeme TB, Molefi M, Chofle AA, Bidwell G, Tsholo K, Tlhako N, Mawoko N, Patel RKK, Tenforde MW, Muthoga C, Bisson GP, Kidola J, Changalucha J, Lawrence D, Jaffar S, Hope W, Molloy SLF, Harrison TS: Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial Clin Infect Dis 68 (3): 393-401,2019.

Sereti Irini, Bisson Gregory P, Meintjes Graeme Ayton (Eds): HIV and Tuberculosis: A Formidable Alliance Springer International Publishing : 2019.

Auld SC, Maenetje P, Ravimohan S, Weissman D, Ncube I, Mlotshawa M, Ratsela N, Chase W, Vangu MDI-T, Wallis R, Churchyard G, Kornfeld H, Bisson GP: Declines in Lung Function after ART initiation in Adults with HIV and TB: A Potential Manifestation of Respiratory IRIS Clin Infect Dis : 2019.

Ravimohan S, Maenetje P, Auld SC, Ncube I, Mlotshwa M, Chase W, Tiemessen CT, Vangu MdT, Wallis R, Churchyard G, Weissman D, Kornfeld H, Bisson GP: A common NLRC4 gene variant associates with inflammation and pulmonary function in HIV/TB Clin Infect Dis : 2019.

Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, Ahmad N, Ahuja SD, Akkerman OW, Alffenaar J-WC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan P-C, Chan ED, Chang K-C, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Holtz TH: Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis Lancet 392 (10150): 821-834,2018.

Vujkovic M, Bellamy S, Zuppa A, Gastonguay M, Moorthy G, Ratshaa B, Han X, Steenhoff A, Mosepele M, Strom B, Bisson GP, Aplenc R, Gross R: Polymorphisms in Cytochrome P450 are associated with Extensive Efavirenz Pharmacokinetics and CNS Toxicities in an HIV Cohort in Botswana Pharmacogenomics J 18 (5): 678-688,2018.

Ngongondo M, Miyahara S, Hughes M, Sun X, Bisson GP, Gupta A, Kumwenda J, Lavenberg J, Torres T, Nyirenda M, Kidonge K, Hosseinpour C, AIDS Clinical Trials Group A5274 (REMEMBER) Study Team: Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial J Acquir Immune Defic Syndr 78 (1): 54-61,2018.

Academic Contact Info

832 Blockley Hall
423 Guardian Drive
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania

Philadelphia, PA 19104-6021
Phone: (215) 573-5811